Dozens of lawsuits are challenging the long-standing belief that pregnant women can safely take acetaminophen, an over-the-counter drug used in Tylenol and generic pain medications.
The District of Columbia’s highest court revived two lawsuits that claim CVS and Walmart are misleading consumers by selling unproven homeopathic products alongside FDA-approved over-the-counter medicines on their store shelves and websites.
A roundup of the week’s most newsworthy health industry press releases from PR Newswire NEW YORK, Sept. 30, 2022 /PRNewswire/ — With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help journalists covering the healthcare industry stay on top of the week’s most newsworthy and popular releases, here’s a roundup of stories from the week that shouldn’t be missed. The list below includes the headline (with a link to the full text) and an excerpt from each story. Click on the press release headlines to access accompanying multimedia assets that are available for download. Closer Study of Major Autism Gene Suggests Possible Treatment Approach Research led by a scientist at Cincinnati Children’s who primarily studies brain tumors may open doors for improved treatment of autism. Alzheimer’s Association Statement on Lecanemab Phase 3 Topline Data Release “On behalf of the more than 6 million Americans living with Alzheimer’s disease and their families, the Alzheimer’s Association enthusiastically welcomes the positive topline data reported today by Eisai and Biogen on the CLARITY AD global Phase 3 clinical trial of lecanemab.” Inflation Is Making It Harder to Pay Medical Bills A Debt.com poll shows fewer Americans have medical debt, but inflation has slowed their payments – so they’re delaying the care they need.
McKesson (MCK) stated Thursday it has extended its partnership with CVS Health to distribute pharmaceuticals through June 2027.
McKesson Corporation (NYSE: MCK) today announced that it has signed an agreement in principle to extend its partnership with CVS Health to distribute pharmaceuticals to mail order and specialty pharmacies, retail pharmacies and distribution centers through June 2027. “We are pleased to continue our long-standing relationship with CVS Health and value the shared commitment of improving health
BALA CYNWYD, Pa., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Signify Health, Inc. (“Signify Health” or the “Company”) (NYSE – SGFY) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the Company’s agreement to be acquired by CVS Health® (NYSE - CVS). Under the terms of the merger agreement, Signify Health shareholders will receive $30.50 in cash for each share of the Company they own, representing a total transaction value of approximately $8 billion.
Reportedly, Walmart and healthcare giant UnitedHealth Group are collaborating to offer preventive care for people aged 65 and up, and virtual healthcare services for all age groups. The 10-year partnership represents Walmart’s latest investment into healthcare that could help the retail giant better compete with CVS Health and Walgreens Boots Alliance. Walmart’s effort with UnitedHealth […]
Four of its products are now in CVS, and Cake is also doubling its products in Walmart to 11 SKUs, the company said. Cake slices into new capital as it expands sexual wellness product placement by Christine Hall originally published on TechCrunch
CVS Health Corporation with ticker code (CVS) have now 23 analysts in total covering the stock. The consensus rating is ''Buy''. The target price ranges between 130 and 98 with a mean TP of 120.57. Given that the stocks previous close was at 98.35 this indicates there is a potential upside of 22.6%. The 50 day MA is 100.17 and the 200 day moving average is 100.63. The company has a market cap of $128,316m. You can visit the company''s website by visiting: https://www.cvshealth.com [stock_market_widget type="chart" template="basic" color="green" assets="CVS" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $157,306m based on the market concensus. CVS Health Corporation provides health services in the United States. The company''s Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.
NEW YORK , Sept. 26, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CVS, XOM, SAVA, MU, and PYPL. … Full story available on Benzinga.com
Home health company Signify Health, which was recently sold to US giant CVS for $8bn, has announced plans to grow its new Galway base to 200 staff by the end of 2024.
Carnegie Capital Asset Management LLC decreased its position in CVS Health Co. by 88.5% during the second quarter, according to the company in its most recent disclosure with…
"We''ve learned that with the right model, the right investment and the right drive, we''re able to guide deserving people across our country to their American dream," Interapt''s CEO said.
Story at a glance CVS Health and Aetna are working to meet The American Foundation for Suicide Prevention’s goal of reducing America’s suicide rate by 20 percent by 2025. The companies have m…
Cano Health (CANO) stock is moving on Friday from reports that Humana (HUM) and CVS (CVS) are considering buying the company.
Yahoo Finance Live anchors discuss reports that Humana and CVS are interested in acquiring Cano Health.
Humana and CVS Health are among the several companies looking to buy senior-care facility operator Cano Health, according to media reports on Thursday, sending Cano’s shares up about 50%. The talks are serious and a deal to purchase Cano could be struck in the next several weeks, the Wall Street Journal said on Thursday citing […]
The state alleged that CVS and other pharmacies failed to prevent the diversion of pills and therefore helped to fuel the opioid crisis.
CVS Health Corp (NYSE: CVS ) and Walmart Inc (NYSE: WMT ) will pay $147.5 million to settle lawsuits regarding West Virginia''s opioid crisis, with CVS shelling out $82.5 million and Walmart approximately $65 million. West Virginia was supposed to proceed to trial on September 26 against the two companies and Walgreens Boots Alliance Inc (NASDAQ: WBA ). Walgreens has not settled, and a trial has been rescheduled for June 2023, … Full story available on Benzinga.com
The state of West Virginia has reached settlements with Walmart and CVS totaling more than $147 million to resolve opioid lawsuits, Attorney General Patrick Morrisey said Tuesday in a news conference.
CHARLESTON, W.Va. - Walmart and CVS Pharmacy have settled with the state of West Virginia for a combined total of $147 million in a lawsuit over the companies'' roles in…
CVS and Walmart have agreed to pay more than $147 million to settle lawsuits related to their alleged roles in West Virginia''s opioid crisis, state Attorney General Patrick Morrisey (R) announced Tuesday. The state alleged the pharmacies failed to maintain effective controls as a distributor and dispenser against diversion that contributed to oversupply of opioids…
CVS Health Corp and Walmart Inc have agreed to pay $147.5 million to settle West Virginia’s claims over their alleged roles in the state’s opioid crisis, state attorney general Patrick Morrisey said Tuesday. CVS agreed to pay $82.5 million and Walmart agreed to pay approximately $65 million, according to the state. West Virginia had been […]
CHARLESTON, W.Va.
CHARLESTON, W.Va. (AP) — Walmart and CVS Pharmacy have settled with the state of West Virginia for a combined total of $147 million in a lawsuit over the companies’ roles in contributing to the oversupply of prescription drugs that fueled the opioid epidemic in the country’s most impacted state, Attorney General Patrick Morrisey announced Tuesday. Walmart and CVS were two lawsuits that were part of a larger trial that was pushed back to June of next year along with Kroger and Walgreens. Morrisey recently announced a settlement with Rite Aid for up to $30 million to resolve similar litigation. The lawsuits allege the pharmacies’ contributions to the oversupply of prescription opioids in the state have caused “significant losses through their past and ongoing medical treatment costs, including for minors born addicted to opioids, rehabilitation costs, naloxone costs, medical examiner expenses, self-funded state insurance costs and other forms of losses to address opioid-related afflictions and loss of lives.” It brings the total settlements by the state in opioid lawsuits to $875 million, including $296 million with manufacturers, $400 million with wholesalers and $177.5 million involving pharmacies. “These settlements won’t bring back the lives lost from the opioid epidemic, but these and other settlements will hopefully provide significant help to those affected the most by this crisis in our state,” Morrisey said during a news conference. “This development also avoided a costly and lengthy trial and at the end of the day, West Virginia will have the highest per capita settlement results in the nation fighting for our people.” Walmart agreed to a settlement of just over $65 million and CVS for $82.5 million.
The U.S. government has sent out over 25 million of the updated COVID-19 booster shots, mostly from Pfizer/BioNTech, as production of the Moderna shot continues to ramp up, a federal health agency said Tuesday. Some U.S. pharmacies, including CVS Health and Walgreens Boots Alliance, also reported on Tuesday that government supply of Moderna''s updated shot remains limited, causing appointments for the product to vary across the country. Both CVS and Walgreens said they are working with the government to acquire more Moderna doses and have not seen any supply issues for the Pfizer booster. In August, the U.S. Food and Drug Administration authorized Pfizer''s and Moderna''s updated booster shots that target the dominant BA.4 and BA.5 omicron subvariants, as the country prepares for a broad fall revaccination campaign. According to the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR), retail pharmacies will be receiving millions more doses of Moderna this week and production is ramping up. "We anticipate supply will continue to increase in the coming weeks," an ASPR spokesperson told Reuters.
CVS Health Corp. and Walmart Inc. have agreed to pay $147.5 million to settle West Virginia’s claims over their alleged roles in the state’s opioid crisis, state attorney general Patrick Morrisey said Tuesday. West Virginia had been prepared to proceed to trial on Sept. 26 against those two companies and Walgreens Boots Alliance. The state […]
We are initiating coverage on Rite Aid. Click here to read our analysis why investors should wholly avoid taking positions in the stock in either direction.
Retailers including Walgreens and CVS are finding it difficult to obtain sufficient supplies of the ADHD medication, Bloomberg reported.
Adderall Shortage Worsens As People Without Drug "Not Able To Focus", May Impact Productivity Adderal supplies in the US are dwindling as pharmacies and patients report shortages. The crux of the problem appears to be a major supplier of the drug for attention deficit/hyperactivity disorder has run into supply chain issues. Patients who find themselves without their medication might experience "withdraw" or even a "crash" that could impact productivity at work. The supply crunch first hit our radar last month when the National Community Pharmacists Association found hundreds of pharmacies across the US had trouble purchasing Adderall and generic versions of the brand in late July. Bloomberg spoke with a dozen patients in California, Indiana, and Michigan who were told by their local pharmacists at CVS Health Corp. or Walgreens Boots Alliance Inc. about a worsening drug shortage. "In some cases, patients were told they might have to wait more than a week to get their medication, which is supposed to be taken every day, " Bloomberg noted.
Popular ADHD drug Adderall is running low nationwide after a pandemic-era surge in demand and a labor shortage at the top manufacturer Teva Pharmaceutical (TEVA), Bloomberg…
The following slide deck was published by CVS Health Corporation in conjunction with this event.
Which pharmacy retailer should you invest in?
CVS Health Backs 2022 Adjusted EPS of $8.40-$8.60 Morningstar
CVS Health Corporation (NYSE:NYSE:CVS) 20th Annual Morgan Stanley Global Healthcare Conference September 13, 2022 8:35 AM ET Company Participants Karen Lynch – President and Chief Executive…
Investors in CVS Health Corporation (Symbol: CVS) saw new options become available today, for the January 2025 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 858 days until expiration the newly available
Ahead of events with investors and analysts, CVS Health Corporation (CVS) and Cigna Corporation (CI), which run two of the leading health insurance businesses in the U.S., reiterated…
Even though mental health challenges aren''t anything new, we are living in a time with a series of unique stressors that are impacting every one of us, such as Russia''s invasion of Ukraine, as well as a pandemic that has stretched two-and-a-half years and continually reminds us that as much as we want to be done with it, we''re still living with a public health emergency that none of us has experienced in our lifetimes. It''s no wonder that people are reporting "alarming" levels of stress, according to the American Psychological Association.
CVS Health agreed to acquire Signify Health. See why it is a great addition to CVS''s move to become more ingrained in the healthcare market.
Plus a look at CVS Health''s plan to buy Signify Health.
CVS Health Corporation (NYSE:CVS) price on Friday, September 09, rose 0.36% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $102.63. A look at the stock’s price movement, the level at last check in today’s session was $102.26, moving within a range at $100.08 and $102.37. The beta … What Can CVS Health Corporation (NYSE: CVS) Expect In 2022? Read More »
CVS Health''s (CVS) unit Aetna said on Thursday it will be entering the individual insurance exchange marketplace in New Jersey with its Aetna CVS Health co-branded insurance…
The collaboration will help Walmart Health “accelerate the transition" to a value-based care model — where competitor CVS also made inroads this week.
A lot companies have failed with some bold attempts to disrupt healthcare, but CVS may have actually done it by never saying that was its intent.
WASHINGTON--(BUSINESS WIRE)--Green America released a new update to its Skip the Slip report on the impacts of paper receipts on forests and climate change, as well as how the chemicals used on receipt paper affect consumer and employee health. The report also features a scorecard that grades 33 major U.S. companies on their progress to address the waste and health risks associated with paper receipts. A major finding of the report is the progress CVS is making to address the impacts of its rec
Room for Improvement: Green America Gives "D" Grades to McDonald''s, 7-Eleven, Burger King, Claire''s, Rite Aid, Safeway, Family Store, Panda Express and Wendy''s. Green America released a new update to its Skip the Slip report on the impacts of paper receipts on forests and climate change, as well as how the chemicals used on receipt paper affect consumer and employee health. The report also features a scorecard that grades 33 major U.S. companies on their progress to address the waste and health risks associated with paper receipts. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220907005907/en/ A major finding of the report is the progress CVS is making to address the impacts of its receipts. In 2017, Green America began urging CVS to address its wasteful, phenol-coated (BPA or BPS) paper receipts. The campaign led to a dialogue between Green America and CVS on alternatives. As a first step, the company implemented BPS-free paper in all 10,000 stores and increased promotion of its digital receipt option to ExtraCare Card members, and 7.3 million customers have signed up.
Walmart on Tuesday defended itself from the accusations that it helped fuel the opioid crisis. New Mexico just started a trial against the retailer, accusing it of dispensing too many pills, per Reuters. But Walmart says some people have sued it for refusing to fill their opioid prescriptions. Walmart says that lawsuits brought against it over its alleged role in the US opioid crisis are "misguided and dangerous to public health" as a new trial in New Mexico starts . Numerous states have accused Walmart and other pharmacies of filling too many opioid prescriptions. In November 2021, a federal jury found that Walmart, CVS, and Walgreens caused hundreds of overdose deaths in two Ohio counties by recklessly distributing pills. Last month, the pharmacies were ordered to pay a combined $650 million . Pharmacies Rite Aid and Giant Eagle had also been named in the filings but settled the lawsuits. But Walmart put out a press release Tuesday defending itself from the accusations, and saying that people have filed lawsuits against the retailer for refusing to fill some opioid prescriptions. "Walmart is helping fight the opioid crisis," the company said.
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Signify Health, Inc. (NYSE: SGFY) to CVS Health Corporation (NYSE: CVS). Under the terms of the proposed transaction, shareholders of Signify will receive $30.50 in cash for each share of Signify that they own. KSF is seeking to determine
CVS Health announced Monday that it''s buying home health care services company Signify Health for about $8 billion.
CVS Health will pay about $8 billion to expand into home care, a practice that could cut costs and keep patients happy, provided they get the help they need. The health care giant is buying Signify Health, a technology company that sends doctors or other care providers to patient homes to assess how they are doing and what help they might need. The deal, announced late Monday, is a way for CVS Health to provide more help to patients where and when they want it, CEO Karen Lynch told analysts Tuesday morning. “The home is increasingly part of that choice,” she said, noting that the deal gives the company a foundation to expand further into home health care. CVS Health runs thousands of drugstores nationally, sells insurance and manages prescription drug coverage. Like competitors Walgreens and UnitedHealth Group, CVS Health also has been delving more into providing care and managing the health of its customers, especially those with chronic or expensive medical conditions. Insurers and employers are pushing more for this approach to help patients stay healthy, on their medications and out of expensive hospitals.
- ← Previous
- 1
- 2
- 3
- …
- 16
- 17
- Next →